Dry powder inhalers: which factors determine the frequency of handling errors?
about
COPD: the patient perspectiveAsthma control: the right inhaler for the right patientCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseThe use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.Device errors in asthma and COPD: systematic literature review and meta-analysis.Comparative study of patients in correct usage of and preference for the Swinghaler and Turbuhaler multidose inhalers.Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.Dry powder inhalers and the right things to remember: a concept review.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Evaluating inhaler use technique in COPD patientsEvaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary diseaseExpert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients.Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.A review of the value of innovation in inhalers for COPD and asthma.The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients.Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium.Role of once-daily glycopyrronium bromide (NVA237) in the management of COPDDry-powder inhalers in patients with persistent airflow limitation: usability and preference.Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.Considerations for managing chronic obstructive pulmonary disease in the elderlyA randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.Customizing inhaled therapy to meet the needs of COPD patients.Ultrasonic nebulization platforms for pulmonary drug delivery.How to set up a severe asthma service.The role of nebulized therapy in the management of COPD: evidence and recommendations.Teaching inhaler use in chronic obstructive pulmonary disease patients.Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.Inhaler devices for patients with COPD.Newer treatments in the management of pediatric asthma.Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery.Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.Evaluation of inhaler techniques among asthma patients seen in Nigeria: an observational cross sectional study.Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices.Late-Onset Asthma: A Diagnostic and Management Challenge.Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.
P2860
Q26764894-97B46D7E-DD0E-4EE9-8332-6E14B6FF927DQ26863778-963FFC28-A8DF-4FCA-9A2E-972A5F599679Q27012625-7CEF76E2-1D34-441D-9BC5-CB31251DD8D9Q30366176-0AF6BEFF-088B-489E-9DB7-C470DA9A3C08Q30429709-D2F05532-6BE7-466E-A15A-5B7D58FCF7EAQ30851180-2E406166-0318-4BEA-9867-771D805A850CQ34379468-40D4FDAA-40BA-4FC9-B4A1-7C55EC381446Q35096988-51B16072-16F7-4276-B26C-046CBCACB1D3Q35426748-EBBDD9D0-324C-4F44-A97F-D0D253886179Q35538249-4B52783E-444A-48FD-AF30-ADC434834B53Q35849367-58F91A6F-5D92-44E0-B8D8-104002187B2CQ35898535-2A9E9C26-9D81-4B29-A52A-3624CCBBADF0Q36385515-68F8088A-FF29-4D7A-AC57-4AB6B244AB4FQ36566243-031B7716-AA20-42AD-BFB9-AEE9893C2B93Q36581576-158BE329-79FA-4628-B29A-FD40C5AA79FDQ36714639-CF5151B2-7812-42B8-8B4C-93A87BE770E8Q36908050-957E4EDF-2B05-4F47-B927-C914BB1E02D4Q37077219-28A81828-5F24-486B-A6CB-C3DC88BF4066Q37120706-6187DD07-5415-4D0D-9783-EC7F315FC010Q37232076-7D73C6FC-85DD-43B6-ADA9-1F5F96CCC03DQ37390386-5A318AB0-AC86-49DD-BBA7-E2A01AE02457Q37396797-FC15C357-9BC3-4477-B3DF-25CCB679BAF8Q37437109-8E2261FA-F2DA-46DE-930C-672968C3CB66Q37702735-418AC1C6-43E7-4176-BF00-03A685F3E304Q37748786-ABA2FFB7-B52E-4641-96C1-96849940EB3CQ37892643-24E7438C-FDE5-49D9-B907-4FC71F014F6EQ37980189-2B24496D-0675-42B6-846C-1C14989372A1Q37983115-911C0B25-5714-4FA9-AE45-4233C80522ADQ38034220-D2C31BC1-A862-4DCC-8987-4D39DB798E8BQ38057220-D68FC1DC-C963-46F6-A8DD-8A699B2927AAQ38066413-235C833A-D94C-4950-A836-159906244035Q38093853-BC90EE35-0964-4374-8B8B-4E3A69248145Q38113498-EE426D5A-3308-4EDD-AB5C-9940FDADC127Q38175421-532F29B8-DC01-4DF1-9A52-C4E9588D2E57Q38209833-2A783322-81DA-45C0-800D-5F3C4B899BA1Q38263469-20DF4C30-5E4E-4FAD-AA8F-C6C105523A50Q38593048-8A398B08-E2FB-493F-B0EA-CC8AEC9308CFQ38761194-FF65CD0D-0B89-47FF-AE43-17F4B728D484Q38842452-93BD086D-894C-4066-BB3F-5260D025938AQ38930261-9A2BBBE1-5A39-4E35-8DFB-CF80FAE32A64
P2860
Dry powder inhalers: which factors determine the frequency of handling errors?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Dry powder inhalers: which factors determine the frequency of handling errors?
@en
Dry powder inhalers: which factors determine the frequency of handling errors?
@nl
type
label
Dry powder inhalers: which factors determine the frequency of handling errors?
@en
Dry powder inhalers: which factors determine the frequency of handling errors?
@nl
prefLabel
Dry powder inhalers: which factors determine the frequency of handling errors?
@en
Dry powder inhalers: which factors determine the frequency of handling errors?
@nl
P2860
P356
P1433
P1476
Dry powder inhalers: which factors determine the frequency of handling errors?
@en
P2093
Jens Dreyhaupt
P2860
P356
10.1159/000109374
P577
2007-10-02T00:00:00Z